У нас вы можете посмотреть бесплатно The Utility of Cxbladder Triage in Microhematuria Evaluation - Expert Discussion или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Pacific Edge Senior Medical Director Dr. Jay Jhaveri hosts an expert panel discussion with Dr. Evan Goldfischer, Dr. Kristen Scarpato, Dr. Ron Loo, and Dr. Zachary Klaassen focused on the use of Cxbladder Triage, a urine-based tumor marker (UBTM) test, in the evaluation of patients presenting with microhematuria. Topics covered include: Incorporating the new AUA/SUFU Microhematuria Guideline* in practice Practical learnings from a recent Kaiser Permanente study of over 3,300 patients** Challenges in incorporating UBTMs in practice – and how to overcome them Leveraging UBTMs to improve practice efficiency UBTMs in the context of recent CMS guidance regarding billing and coding Learn more: Email us at [email protected] / [email protected] Visit us at www.cxbladder.com Biographies: Evan Goldfischer, MD, MBA, FACS, Premier Medical Group, Poughkeepsie, NY Kristen Scarpato, MD, MPH, Associate Professor, Department of Urology, Vanderbilt University, Nashville, TN Ronald K. Loo, MD, Urologist, Kaiser Permanente, CA Zachary Klaassen, MD, MSc, Urologic Oncologist, Assistant Professor Surgery/Urology at the Medical College of Georgia at Augusta University, Wellstar MCG, Georgia Cancer Center, Augusta, GA Jay Jhaveri, MD, Senior Medical Director, Pacific Edge References: (*) Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak L, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 0(0). doi: 10.1097/JU.0000000000004490. (**) Loo R.K., et al (2025) Clinical Utility of a Urine Biomarker (Cxbladder Triage) Compared to a Standard of Care for Microscopic Hematuria Evaluations in a Large Independent Delivery Network. Abstract submitted to the AUA 2025 meeting.